Literature DB >> 26667374

Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity.

Z A Cope1, S B Powell1,2, J W Young1,2.   

Abstract

Numerous psychiatric disorders whose cognitive dysfunction links to functional outcome have neurodevelopmental origins including schizophrenia, autism and bipolar disorder. Treatments are needed for these cognitive deficits, which require development using animal models. Models of neurodevelopmental disorders are as varied and diverse as the disorders themselves, recreating some but not all aspects of the disorder. This variety may in part underlie why purported procognitive treatments translated from these models have failed to restore functioning in the targeted patient populations. Further complications arise from environmental factors used in these models that can contribute to numerous disorders, perhaps only impacting specific domains, while diagnostic boundaries define individual disorders, limiting translational efficacy. The Research Domain Criteria project seeks to 'develop new ways to classify mental disorders based on behavioral dimensions and neurobiological measures' in hopes of facilitating translational research by remaining agnostic toward diagnostic borders derived from clinical presentation in humans. Models could therefore recreate biosignatures of cognitive dysfunction irrespective of disease state. This review highlights work within the field of neurodevelopmental models of psychiatric disorders tested in cross-species translational cognitive paradigms that directly inform this newly developing research strategy. By expounding on this approach, the hopes are that a fuller understanding of each model may be attainable in terms of the cognitive profile elicited by each manipulation. Hence, conclusions may begin to be drawn on the nature of cognitive neuropathology on neurodevelopmental and other disorders, increasing the chances of procognitive treatment development for individuals affected in specific cognitive domains.
© 2015 John Wiley & Sons Ltd and International Behavioural and Neural Genetics Society.

Entities:  

Keywords:  CNTRICS; Research Domain Criteria; cognition; cross-species; developmental; mice; motivation; rats; translational

Mesh:

Year:  2016        PMID: 26667374      PMCID: PMC4961087          DOI: 10.1111/gbb.12268

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  170 in total

1.  Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study.

Authors:  John J McGrath; Darryl W Eyles; Carsten B Pedersen; Cameron Anderson; Pauline Ko; Thomas H Burne; Bent Norgaard-Pedersen; David M Hougaard; Preben B Mortensen
Journal:  Arch Gen Psychiatry       Date:  2010-09

Review 2.  CNTRICS final task selection: long-term memory.

Authors:  John D Ragland; Roshan Cools; Michael Frank; Diego A Pizzagalli; Alison Preston; Charan Ranganath; Anthony D Wagner
Journal:  Schizophr Bull       Date:  2008-10-16       Impact factor: 9.306

Review 3.  NCAM in neuropsychiatric and neurodegenerative disorders.

Authors:  Leann H Brennaman; Patricia F Maness
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

4.  From antipsychotic to anti-schizophrenia drugs: role of animal models.

Authors:  Mark A Geyer; Berend Olivier; Marian Joëls; René S Kahn
Journal:  Trends Pharmacol Sci       Date:  2012-07-16       Impact factor: 14.819

5.  Effects of sex and COMT genotype on environmentally modulated cognitive control in mice.

Authors:  Francesco Papaleo; Lucy Erickson; Guangping Liu; Jingshan Chen; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-19       Impact factor: 11.205

6.  Increased risk-taking behavior in dopamine transporter knockdown mice: further support for a mouse model of mania.

Authors:  Jared W Young; Jordy van Enkhuizen; Catharine A Winstanley; Mark A Geyer
Journal:  J Psychopharmacol       Date:  2011-03-18       Impact factor: 4.153

7.  Association of autistic spectrum disorder with season of birth and conception in a UK cohort.

Authors:  Karen J Hebert; Laura L Miller; Carol J Joinson
Journal:  Autism Res       Date:  2010-08       Impact factor: 5.216

Review 8.  Seasonality of births in schizophrenia and bipolar disorder: a review of the literature.

Authors:  E F Torrey; J Miller; R Rawlings; R H Yolken
Journal:  Schizophr Res       Date:  1997-11-07       Impact factor: 4.939

Review 9.  Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.

Authors:  J W Young; M A Geyer
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

10.  Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice.

Authors:  Hiroko Koike; P Alexander Arguello; Mirna Kvajo; Maria Karayiorgou; Joseph A Gogos
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-16       Impact factor: 11.205

View more
  17 in total

Review 1.  Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Jared W Young
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 2.  Translating advances in the molecular basis of schizophrenia into novel cognitive treatment strategies.

Authors:  Colm M P O'Tuathaigh; Paula M Moran; Xuechu C Zhen; John L Waddington
Journal:  Br J Pharmacol       Date:  2017-08-03       Impact factor: 8.739

3.  Developmental emergence of persistent memory for contextual and auditory fear in mice.

Authors:  Rojina Samifanni; Mudi Zhao; Arely Cruz-Sanchez; Agarsh Satheesh; Unza Mumtaz; Maithe Arruda-Carvalho
Journal:  Learn Mem       Date:  2021-10-18       Impact factor: 2.460

Review 4.  Psychoactive drug exposure during breastfeeding: a critical need for preclinical behavioral testing.

Authors:  Irving Zucker
Journal:  Psychopharmacology (Berl)       Date:  2018-03-16       Impact factor: 4.530

Review 5.  Neurobehavioural complications of sleep deprivation: Shedding light on the emerging role of neuroactive steroids.

Authors:  Roberto Frau; Francesco Traccis; Marco Bortolato
Journal:  J Neuroendocrinol       Date:  2019-09-30       Impact factor: 3.627

6.  Relationship between effortful motivation and neurocognition in schizophrenia.

Authors:  Andrew W Bismark; Michael L Thomas; Melissa Tarasenko; Alexandra L Shiluk; Sonia Y Rackelmann; Jared W Young; Gregory A Light
Journal:  Schizophr Res       Date:  2017-06-30       Impact factor: 4.939

7.  The developmental origins of complex behavior and neuropsychiatric disease.

Authors:  Andrew Holmes
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

Review 8.  The 5 choice continuous performance test (5C-CPT): A novel tool to assess cognitive control across species.

Authors:  Savita G Bhakta; Jared W Young
Journal:  J Neurosci Methods       Date:  2017-07-25       Impact factor: 2.390

Review 9.  Sleep Spindle Characteristics in Children with Neurodevelopmental Disorders and Their Relation to Cognition.

Authors:  Reut Gruber; Merrill S Wise
Journal:  Neural Plast       Date:  2016-07-11       Impact factor: 3.599

Review 10.  From the Clinic to the Laboratory, and Back Again: Investigations on Cannabinoids and Endocannabinoid System Modulators for Treating Schizophrenia.

Authors:  Kurt Leroy Hoffman
Journal:  Front Psychiatry       Date:  2021-07-05       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.